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Abstract: Migraine is defined as a disorder characterized by intermittent headache episodes, 
accompanied with nausea, photophobia and/or phonophobia. Pharmacological therapy is in 
accordance with the severity of pain and may include acute, prophylactic and most commonly 
both approaches. The aim of the acute therapy is stopping or alleviating the attack or progres-
sion of the pain and, in case of a migraine attack that has started, lessening the pain. Preventive 
therapy aims to reduce attack frequency and severity. This study was designed to evaluate the 
effect of dietary factors in the management and prophylaxis of migraine in cases diagnosed as 
having migraine disorder according to the 2003-IHS criteria. Fifty consecutive Turkish patients 
(13 men, 37 women) with diagnosis of migraine were randomly divided into two groups for 
treatment protocols with the written approval of the ethics committee. The cases in the first group 
(K) were treated with metoprolol, vitamin B2 (riboflavin), and naproxen sodium just at the aura 
or at the beginning of the attacks. The cases in the second group (D) were also supplied with a 
comprehensive dietary list arranged by our algology clinic in addition to the same medication 
protocol. There were no demographic differences between the cases (P  0.05). VAS scores 
were lower in group D than group K (P  0.01), and also the migraine attack frequencies and 
monthly amounts of analgesic consumed amounts were also statistically significantly less. It 
was concluded that beta-blocker and riboflavin therapy supplemented with a convenient diet 
with appropriate alternatives in patients with migraine disorder was associated with statistically 
significant decreases in headache frequency, intensity, duration and medication intake.
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Introduction
Migraine is defined as a disorder characterized by intermittent headache episodes, 
accompanied with nausea, photophobia and/or phonophobia.1 Migraine attacks seem 
to result from pathophysiological mechanisms activated by specific trigger factors. 
The recurrence of migraine attacks may depend either on a reduced threshold or 
on particularly strong or frequent trigger factors or both.2 Biochemical research has 
provided evidence for certain physiologic characteristics in migraineurs, which have 
been proposed as predisposing factors for migraine. These include platelet serotonin 
(5-HT) metabolism, platelet activation, increased sensitivity to nitric oxide (NO) 
donors, reduced levels of metabolic enzymes, abnormal opiate receptor function, and 
electro-encephalographic (EEG) abnormalities.3
Pharmacological therapy, in accordance with the severity of pain, may include 
acute or prophylactic and most commonly both approaches. Acute therapy is stop-
ping or alleviating the attack or progression of the pain and, in case of a migraine Journal of Pain Research 2010:3 126
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attack that has started, attempts to lessen the pain. Preven-
tive   treatment is indicated when the attacks are long lasting, 
severe and disabling and do not respond to acute treatments.4 
Preventive therapy aims to reduce attack frequency and 
severity.5 The preventive treatment for migraine includes 
beta-blockers, antidepressants, calcium channel antago-
nists, serotonin antagonists, non-steroid anti-inflammatory 
drugs (NSAIDs), riboflavin (vitamin B2) at high doses and 
anticonvulsant drugs.6
An understanding of the aura and headache components 
of migraine provide a basis for the potential mechanisms of 
action of dietary triggers. Dietary migraine triggers may influ-
ence the pathophysiology of migraine at one or more phases 
of the migraine attack. They could affect the cerebral cortex, 
trigeminal nerve, brainstem trigeminal nuclei, thalamus, and 
brainstem or limbic pathways. The chemical trigger may 
stimulate neuroreceptors, cause release of neurotransmitters, 
or have a direct effect on neurons within the trigeminovascular 
migraine pathways.7
We conducted our study on 50 patients who were diag-
nosed with migraine [according to the 2003-  International 
Headache Society (IHS) criteria8 (Table 1)]. In our research, 
we could not find any studies previously conducted with an 
extended diet list covering foodstuffs that are acknowledged 
to trigger migraine attacks. Thus, by completely removing 
some foodstuffs that we listed as   triggering migraine head-
aches in various studies (having regard to dietary habits 
of Turkish society) from the daily diet lists of patients, we 
wanted to observe the effect on the consumption of anal-
gesic medicines used for migraine headaches (  recurrence 
and severity).
Method
With the written approval of the ethics committee, we started 
our study with 56 patients. However, 6 patients left the study 
or were ineligible for various reasons. Therefore 50 consecu-
tive Turkish patients (13 men, 37 women) with diagnosis of 
migraine were randomly divided into 2 groups for treatment 
protocols. Cases with menstruational migraine were excluded 
from the study. Patients in each group were well informed about 
their diseases and the treatment modalities were applied.
Patients in the first group (Group K) were treated with 
metoprolol (120 mg/day), vitamin B2 (riboflavin 600 mg, 
3 times a day), and naproxen sodium (550 mg) just at the 
aura or at the beginning of the attacks.
In addition to being provided with the same medication 
protocol, patients in the second group (Group D) were also 
supplied with a comprehensive dietary list (Table 2) arranged 
by our algology clinic. Furthermore, patients were also 
informed about the visual analog scale (VAS) and keeping 
a daily pain diary (DPD). They were asked to record their 
headache VAS scores, attack frequencies and severities and 
also naproxen sodium consumption starting from the begin-
ning of the therapy.
Patients were recalled for control examinations every 15 
days and their data (with special attention to their DPD) were 
recorded throughout a year.
All data were collected in an Excel® spread sheet for 
documentation. For statistical analysis, SPSS 13.0® for Win-
dows (LEAD Technologies Inc, USA, 2004) was used. The 
Mann-Whitney U test was used to compare the differences 
between demographic data of patients such as age, length 
and weight; and Chi square test was used to compare the 
Table 1 IHS criteria for the diagnosis of migraine
Migraine without aura Migraine with aura
A 5 attacks fulfilling criteria B – D, and not attributed to another disorder A 2 attacks fulfilling criteria B and C and not attributed to another 
  disorder
B Attacks lasting 4–72 hours (untreated or unsuccessfully treated)
 
C Headache has 2 of the following characteristics:
 C 1 Unilateral location
 C 2 Pulsating quality
 C 3 Moderate or severe intensity (inhibits or prohibits daily activities)
 C 4 Aggravation by, or causing avoidance of, routine physical activity
B Aura consisting of 1 of the following fully reversible symptoms but 
no motor weakness:
 B 1 Visual symptoms (flickering lights, spots/lines, and/or loss of vision)
 B 2 Sensory symptoms (ie, “pins and needles” and/or numbness)
 B 3 Dysphasic speech disturbance
 
C 2 of the following:
D During headache 1 of the following:
 D 1 Nausea and/or vomiting
 D 2 Photophobia and phonophobia
   C 1 Homonymous visual symptoms and/or unilateral sensory 
  symptoms
   C 2 Aura develops gradually over 5 min and/or different aura 
  symptoms occur in succession over 5 min
 C 3 Each symptom lasts 5 min and 60 min
Adapted from Cephalalgia.8Journal of Pain Research 2010:3 127
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difference between gender and migraine type. The Mann-
Whitney U test was also used to compare the differences 
between monthly VAS, monthly number of attacks and 
monthly analgesic consumption of the two groups. Statistical 
significance was defined as P  0.05.
Results
There were no demographic differences between the cases 
(P  0.05) (Table 3). VAS scores were lower in Group D than 
in Group K (P  0.01), and the migraine attack frequencies 
and monthly analgesic consumption amounts were also sig-
nificantly lower (P  0.01) (Table 4).
Discussion
The pharmacological treatment of migraine may be acute 
or preventive, and patients who experience frequent severe 
headache attacks often require both approaches. The con-
temporary guidelines include few prophylactic drugs under 
Table 2 Dietary list used for the patients in our algology clinic
Foods to avoid/limit Alternatives
Beverages
Cola Non-cola soft drinks
Coffee No more than 1 cup
Tea No more than 2 cups
Chocolate drinks or cocoa Non-chocolate drinks
Alcoholic beverages, red wine in particular Vodka, Sauterne or Riesling wines
Fruit juices, decaffeinated drinks, flavored waters should be preferred
Dairy products
Milk Low-fat or skim milk
Buttermilk and cream
Cream Butter/margarine
Cheddar, Brie, processed cheeses, aged cheeses (Parmesan, Romano), fats, lard Vegetable oils
Meats/poultry/seafood
Ham, bacon, offal – chicken livers Fresh and non-processed meats
Aged, cured, canned, or marinated meats – pepperoni, salami Eggs when limited to no more than 3 per week
Salted, smoked, and dried fish Fresh or frozen fish, canned tuna or salmon
Processed meats – hot dogs, bologna
Pickled herring
Vegetables
Certain navy beans, pinto beans, pole beans, lentils, garbanzo beans, broad beans String beans
Most peas Onion when used only for flavoring
Sauerkraut, olives, and pickles Asparagus, beets, carrots, spinach, tomatoes, squash, corn, 
zucchini, broccoli, lettuce, potatoes
Grains, breads, cereals
Yeast breads – most white breads Whole wheat, rye, English muffins, Melba toast, bagels
Doughnuts Most cereals
Sourdough Rice, pasta
Crackers with cheese and pastries containing chocolate or nuts
Soups
Canned soups Soups without MSG or yeast
Soup cubes and bouillon cubes with MSG
Fruits
Figs, raisins, plums, papaya, pineapple, avocados, kiwifruit Apples, prunes, cherries, grapes, apricots, peaches, pears
Citrus fruits, bananas Limit citrus fruits and bananas to 1/2 to 1 serving per day
Desserts/snack foods
Chocolate, ice cream Fruits as above, sherbets, ices, sorbets
Cookies and cakes made with yeast cakes/cookies made without yeast
Potato chip products Pretzels
Nuts/seeds, puddings
Additives
MSG Wine vinegar
Seasonings and spices Limited use of soy sauce
Artificial sweeteners Small amounts of salad dressingJournal of Pain Research 2010:3 128
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the recommendations of Group I on the basis of evidence, 
scientific effect and clinical assessment. They are: ami-
triptyline, atenolol, propranolol, flunarizine, and valproate 
sodium. Group II includes: nonsteroidal anti-inflammatory 
drugs, specifically naproxen and naproxen sodium as well 
as lornoxicam; antiepileptic drugs gabapentin, lamotrigine, 
topiramate; calcium channel blockers verapamil and cin-
narizine; selective serotonin reuptake inhibitor fluoxetine; 
beta-blockers (metoprolol and nadolol); dihydroergotamine 
and vitamin B2.9
How beta-blockers reduce attack frequency in migra-
neurs is not clear, although it is probably by acting on the 
central monoaminergic system and serotonin receptors. Not 
all of these drugs are effective, and those used in migraine 
prophylaxis include atenolol, metoprolol, nadolol and 
  propranolol.10–15
Vitamin B2 is a water-soluble essential precursor to 
flavin mononucleotides necessary for electron transport 
within the Krebs cycle. It is essential to normal production 
of ATP and thus for maintaining membrane stability and 
for all energy-related cellular functions.16 A mitochondrial 
dysfunction causing impaired oxygen metabolism may play 
a role in migraine pathogenesis. Riboflavin at high doses (up 
to 400 mg) showed good effectiveness in preventing migraine 
attacks with a low rate of unwanted side effects, such as mild 
abdominal pain and diarrhea.17
The role of dietary factors in provoking migraine attacks 
is of increased interest.18–21 The role of serotonin (5-HT) 
in migraine has intrigued investigators observing that the 
migraine attack is associated with an increased excretion of 
serotonin metabolites.22 Serotonin released from hypersensi-
tive platelets has been suggested as one of the precipitators of 
the vasoconstrictor phase of migraine. A reduction in platelet 
serotonin might thus have a beneficial effect.
Such a reduction could theoretically be achieved by a 
reduced dietary intake of serotonin and the serotonin precur-
sor tryptophan (TRP).23,24 A carbohydrate-rich meal, with 
subsequent insulin secretion, increases the availability of TRP 
to the brain and thereby also the serotonin synthesis in the 
brain.25 TRP is the scarcest of the amino acids and constitutes 
on average only about 1/100th of the total amino acid content 
of proteins. The dietary intake of TRP and protein is usually 
considerably higher than the required amount. However, an 
increased serotonin level in the brain is probably helpful in 
alleviating migraine headache, since serotonin is known to 
be involved in the anti-nociceptive system.26
A variety of amines have been implicated in the 
development of headache, most commonly tyramine (TYR), 
histamine (HIS), and beta-phenylethylamine (PEA).27–28 
Cheeses, peanuts, meats, and alcohol are known to contain 
TYR, HIS, and PEA. Citrus fruits contain octopamine and 
synephrine. All of these foods has been implicated clinically 
to be causally related to headache activity.
One of the most commonly cited food triggers of headache 
is chocolate. Chocolate is especially rich in a variety of 
vasoactive amines including PEA, which crosses the blood–
brain barrier and effects cerebral blood flow. Headache may 
therefore be related to a different metabolism. Theobromine, 
a methylxanthine found in cocoa that is similar in chemical 
structure to caffeine may act as a headache trigger.29
Many people believe that by avoiding some specific foods 
it is possible to reduce the frequency of migraine attacks. 
Putative allergic factors are often considered responsible 
for migraine attacks, whereas, only in rare cases, a specific 
food directly causes migraine. By contrast, fasting has been 
described to be a precipitating factor in 25% of children and 
in 40% of adults affected. Also, some foods are involved as 
precipitating factors in percentages varying from 10% to 
Table 3 Demographic values of the patients
Group Age (Year) Sex (M/W) Height (cm) Weight (kg) Type* of migraine (1/2)
Group K 44.61 ± 12.39 5/20 165.79 ± 7.15 72.49 ± 12.43 8/17
Group D 42.02 ± 10.15 8/17 167.35 ± 9.72 77.41 ± 14.85 10/15
P values 0.87 0.05 0.86 0.44 0.05
*Type 1, migraine without aura; Type 2, migraine with aura.
Table 4 Monthly VAS, number of attacks and analgesic consumption rates of the patients
Group Monthly VAS Monthly number of attacks Monthly analgesic consumption
Group K 0.88 ± 0.53 5.15 ± 1.33 3.64 ± 0.76
Group D 0.44 ± 0.51 2.70 ± 1.59 1.88 ± 0.78
P values 0.006 0.007 0.003Journal of Pain Research 2010:3 129
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45%, namely: chocolate, cheese, some fruits, citrus fruits, 
fatty foods and fried food.30 Table 5 lists potential food items 
that have been reported to trigger migraine headaches and 
the chemical constituent thought to be specifically involved 
in the mechanism of the attack.7
Some dietary restriction studies have reported a 
decrease in headache after participation in an elimination 
diet.31,32 In contrast some studies have found that dietary 
restriction does not significantly decrease headache33 or 
that placebos are as likely to result in headache as chal-
lenge foods.34
Peatfield35 recorded 19% of patients reporting sensitivity 
to cheese, chocolate, or both, and 11% of patients sensitive to 
citrus fruits. The exact mechanism of these migraine attacks 
is unknown, although migraines are believed to be caused 
by a chemical reaction consisting of the release of serotonin 
from the intestinal wall, or by an enzymatic defect, and not 
by allergic reactions.
Peatfield studied 60 patients with migraine − mean dura-
tion of migraines was 18 years for women and 22 years for 
men. When patients were put on an exclusion diet, in most 
cases, migraines disappeared by the fifth day. The mean 
number of foods causing symptoms was 10 per patient, the 
most frequent offenders being wheat, orange, egg, tea and 
coffee, chocolate and milk, beef, corn, cane sugar, and yeast, 
mushrooms, and peas. When offending foods were avoided, 
all patients improved. In fact, the number of headaches fell 
from 402 to 6 per month, with 85% of the subjects becoming 
headache free.35
Elimination diets have been shown to be valuable in 
treating migraine. When 88 children with severe migraines 
were put on an oligoantigenic diet, 93% improved.31 In 
another study of 17 patients who completed an elimination 
diet, migraine attacks were found to be most frequently 
caused by cow’s milk (10 out of the 17). Other culprits 
included flour, eggs, cheese, pork, and artificial colors and 
preservatives.36,37
In this study we tried to prepare a detailed and strict 
dietary program that avoided food that is believed to pre-
cipitate migraine attacks. In light of the previous studies 
on this subject patients can also be offered alternative food 
choices. We believe that avoiding stress is as effective as diet 
and prophylactic medications in the prevention of headache 
episodes. The findings of this study revealed decreased sever-
ity and frequency of headache episodes and less analgesic 
consumption in the group that was treated with the dietary 
list, verifying our hypothesis.
Conclusions
It was determined that beta-blocker and riboflavin therapy 
supplied with an appropriate diet (with alternatives) was 
associated with statistically significant decreases in headache 
frequency, intensity, duration and medication intake. The 
prevention of headaches by attention to precipitating factors 
may be preferable to long-term prophylactic drug treatment 
with attending adverse reactions.
We once again ascertained in this study that diet is of great 
importance in migraine treatment. Throughout the course of 
treatment, we observed many positive effects of an appro-
priate diet list and its correct application on patients with 
migraine. We believe more positive results can be achieved 
if a diet list is attached to prescriptions.
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